DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Vermorken JB, Trigo J, Hitt R, Koralewski P, Diaz-Rubio E, Rolland F. et al.
Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy.
J Clin Oncol 2007;
25: 2171-7
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.